AU4070289A - Monoclonal antibody for inhibiting cell infection by hiv viruses - Google Patents
Monoclonal antibody for inhibiting cell infection by hiv virusesInfo
- Publication number
- AU4070289A AU4070289A AU40702/89A AU4070289A AU4070289A AU 4070289 A AU4070289 A AU 4070289A AU 40702/89 A AU40702/89 A AU 40702/89A AU 4070289 A AU4070289 A AU 4070289A AU 4070289 A AU4070289 A AU 4070289A
- Authority
- AU
- Australia
- Prior art keywords
- monoclonal antibody
- inhibiting cell
- cell infection
- hiv viruses
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3828582A DE3828582A1 (en) | 1988-08-23 | 1988-08-23 | MONOCLONAL ANTIBODY TO INHIBIT THE INFECTION OF CELLS BY HIV VIRUSES |
DE3828582 | 1988-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4070289A true AU4070289A (en) | 1990-03-23 |
AU629847B2 AU629847B2 (en) | 1992-10-15 |
Family
ID=6361424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40702/89A Ceased AU629847B2 (en) | 1988-08-23 | 1989-08-22 | Monoclonal antibody for inhibiting cell infection by hiv viruses |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0430999A1 (en) |
JP (1) | JPH04501055A (en) |
AU (1) | AU629847B2 (en) |
DE (1) | DE3828582A1 (en) |
DK (1) | DK24891D0 (en) |
ES (1) | ES2018387A6 (en) |
WO (1) | WO1990002199A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10227564B2 (en) | 2010-12-02 | 2019-03-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3919294C2 (en) * | 1989-06-13 | 1998-04-23 | Frank Prof Dr Emmrich | Use of a monoclonal antibody to treat an autoimmune disease |
US5961976A (en) * | 1996-06-03 | 1999-10-05 | United Biomedical, Inc. | Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV |
US11180555B2 (en) | 2014-09-16 | 2021-11-23 | Ubi Us Holdings, Llc. | Antibodies directed against CD4 for the treatment and functional cure of HIV |
EP3497133A4 (en) | 2016-08-13 | 2020-03-25 | UBI IP Holdings | Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683295A (en) * | 1984-05-24 | 1987-07-28 | Scripps Clinic And Research Foundation | Method for the preparation of anti-receptor antibodies |
FR2570278B1 (en) * | 1984-09-14 | 1987-02-13 | Pasteur Institut | COMPOSITIONS AND METHOD FOR PROTECTING T CELLS FROM THE ETIOLOGICAL AGENT OF LYMPHADENOPATHIES AND ACQUIRED IMMUNODEPRESSION SYNDROME |
EP0280710B1 (en) * | 1986-08-21 | 1996-03-20 | The Trustees Of Columbia University In The City Of New York | Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids |
FI891226A (en) * | 1988-04-28 | 1989-10-29 | Univ Leland Stanford Junior | RESEPTORDETERMINANTER I ANTI-T-CELLER FOER BEHANDLING AV AUTOIMMUNSJUKDOM. |
DE69020914T2 (en) * | 1989-01-23 | 1996-03-07 | Abbott Lab | Monoclonal antibodies from rats to human antigens and methods for their production. |
-
1988
- 1988-08-23 DE DE3828582A patent/DE3828582A1/en not_active Withdrawn
-
1989
- 1989-08-22 AU AU40702/89A patent/AU629847B2/en not_active Ceased
- 1989-08-22 WO PCT/EP1989/000986 patent/WO1990002199A1/en not_active Application Discontinuation
- 1989-08-22 JP JP1508890A patent/JPH04501055A/en active Pending
- 1989-08-22 EP EP89909393A patent/EP0430999A1/en not_active Ceased
- 1989-08-23 ES ES8902912A patent/ES2018387A6/en not_active Expired - Lifetime
-
1991
- 1991-02-13 DK DK024891A patent/DK24891D0/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10227564B2 (en) | 2010-12-02 | 2019-03-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD) |
US10577588B2 (en) | 2010-12-02 | 2020-03-03 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GVHD) |
Also Published As
Publication number | Publication date |
---|---|
ES2018387A6 (en) | 1991-04-01 |
EP0430999A1 (en) | 1991-06-12 |
DK24891A (en) | 1991-02-13 |
JPH04501055A (en) | 1992-02-27 |
WO1990002199A1 (en) | 1990-03-08 |
DK24891D0 (en) | 1991-02-13 |
DE3828582A1 (en) | 1990-03-01 |
AU629847B2 (en) | 1992-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5267190A (en) | Modified antibodies | |
AU589635B2 (en) | Antibody conjugates | |
LTIP1793A (en) | Method for detecting antibodies against hiv virus | |
AU2843889A (en) | Antigen antibody conjugate | |
AU7041996A (en) | Antibody specific for beta1->6N- acetylglucosamininyltransferase | |
AU590462B2 (en) | Immunoglobulin conjugates | |
AU8746582A (en) | Hepatitis b virus e type antigen | |
AU5103085A (en) | Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity | |
AU3234789A (en) | 2-(2-(substituted)pyrid-3-yl oxy)-4,6-dimethoxy-pyrimidines | |
AU7160691A (en) | Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes | |
AU4070289A (en) | Monoclonal antibody for inhibiting cell infection by hiv viruses | |
AU4450389A (en) | Anti-fucosylcermiade monoclonal antibody | |
AU1718288A (en) | Method for detecting antibodies to human immunodeficiency virus | |
AU7912887A (en) | Monoclonal antibodies to fibrin | |
AU5265686A (en) | Monoclonal anti-alpha-amylase antibody | |
AU600015B2 (en) | Stacker | |
IT215551Z2 (en) | COLLECTOR PARTICULARLY FOR BLOCKING SHEETS. | |
AU2878989A (en) | Antibody conjugates | |
AU3829189A (en) | Detecting antigens or antibodies | |
AU5225693A (en) | Human monoclonal antibodies to human immunodeficiency virus | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
AU618720B2 (en) | Monoclonal antibodies | |
AU565485B2 (en) | Supported viral antigen | |
GB8513057D0 (en) | Dealing port depositing & disbursing mechanism | |
AU6885591A (en) | Monoclonal antibodies specific for acetyl cholinesterase |